Topic: Spiriva

1 chapters across the catalog

Sebelius Double Speak
Episode 122 39:38 - 41:50

122: Sebelius Double Speak

Spiriva COPD Inhaler, Pharmaceutical Advertising Disclaimers

The pharmaceutical advertisement for Spiriva, a daily maintenance treatment for COPD and emphysema, is noted for its unusually long one-minute duration. The ad features extensive disclaimers regarding side effects such as vision changes, glaucoma, and prostate issues. Modern drug marketing often utilizes these disclaimers as a psychological tool to build perceived transparency with consumers.